SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.